02815nam 22006014a 450 991045019080332120200520144314.092-808-7091-21-4237-6606-7(CKB)1000000000246804(EBL)829913(OCoLC)826486220(SSID)ssj0000234953(PQKBManifestationID)11201071(PQKBTitleCode)TC0000234953(PQKBWorkID)10241939(PQKB)11387717(MiAaPQ)EBC829913(Au-PeEL)EBL829913(CaPaEBR)ebr10120740(EXLCZ)99100000000024680420050419d2005 uf 0engur|n|---|||||txtccrRegulating bioprospecting[electronic resource] institutions for drug research, access, and benefit-sharing /Padmashree Gehl SampathTokyo ;New York United Nations University Press20051 online resource (288 p.)Description based upon print version of record.92-808-1112-6 Includes bibliographical references (p. 251-267) and index.Bioprospecting for drug research : an overview -- Drug R&D and the structure of the industry -- International policy dimensions of bioprospecting -- Transaction costs and their impact on the market for bioprospecting -- Intellectual property rights on traditional medicinal knowledge : a process oriented perspective -- The scope of the right to regulate access.Bioprospecting, or the search for useful biochemical compounds and genes in nature, has been the focus of international negotiations for more than a decade, yet the debate on the terms for access to genetic resources, traditional knowledge and benefit-sharing is far from settled.This book examines the optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research. Focusing on the economics of contracts, it shows that the rights exchanged are complementary at each stage of drug discovery and the development of genetic resources.Defining and enforDrugsPatentsGenesPatentsDrugsTestingLaw and legislationGenetic engineeringLaw and legislationElectronic books.DrugsGenesDrugsTestingLaw and legislation.Genetic engineeringLaw and legislation.344.04/233Sampath Padmashree Gehl864097MiAaPQMiAaPQMiAaPQBOOK9910450190803321Regulating bioprospecting1928743UNINA